Interleukin-17A in Alzheimer’s disease: recent advances and controversies

Volume: 19, Pages: 1 - 1
Published: Aug 23, 2021
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease which mainly affects older adults. Although the global burden of AD is increasing year by year, the causes of AD remain largely unknown. Numerous basic and clinical studies have shown that interleukin-17A (IL-17A) may play a significant role in the pathogenesis of AD. A comprehensive assessment ofthe role of IL-17A in AD would benefit the diagnosis, understanding of etiology and...
Paper Details
Title
Interleukin-17A in Alzheimer’s disease: recent advances and controversies
Published Date
Aug 23, 2021
Volume
19
Pages
1 - 1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.